| Product No | EMEA/H/C/002510 |
|---|---|
| Brand Name | Sabervel |
| Nonproprietary Name | irbesartan |
| API | irbesartan |
| ATC Code | C09CA04 |
| Indications | Sabervel is indicated in adults for the treatment of essential hypertension.It is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen. |
| Orphan Drug | no |
| Generics | yes |
| Marketing Authorization Holder | Pharmathen S.A. |
| Status | Withdrawn |
| Authorization Date | 2012-04-13 |
| Version | 2 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information